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In ST-segment elevation myocardial infarction (STEMI) patients treated by primary 
percutaneous coronary intervention (PPCI), the myocardial salvage index (MSI) 
provides a more sensitive measure for assessing the efficacy of novel cardioprotective 
therapies, than an absolute reduction in myocardial infarct (MI) size. Knowledge of 
the MI size and the size of the area-at-risk (AAR) are pre-requisites for measuring the 
MSI, and both may be obtained by cardiovascular magnetic resonance (CMR) in 
reperfused STEMI patients, with the MSI shown to predict clinical outcomes 
following PPCI 1. CMR is considered the gold standard imaging modality for 
quantifying MI size, and it can also delineate the edema-based AAR, with T2 and T1-
mapping CMR emerging as the most robust techniques 2, although no consensus has 
yet been reached. 
In this issue of Circulation: Cardiovascular Imaging, Garg et al 3 report on a 
potentially novel approach for quantifying the AAR, chronic MI size, and MSI in a 
study of 50 STEMI patients reperfused by PPCI, based on extracellular volume 
fraction (ECV) maps from an acute CMR scan. The study derived specific ECV cut-
off values on an acute CMR scan (performed at a median of 48 hours post-PPCI) in a 
subset of 10 patients, to delineate the AAR (when compared to T2-STIR imaging), 
and chronic MI size (when compared late gadolinium enhancement [LGE]) on a 
follow-up scan performed at 3 months post-PPCI). Using acute ECV cut-off values of 
>33% to delineate the AAR and >46% to delineate chronic MI size, they concluded 
that acute ECV maps could be used to reliably quantify AAR, chronic MI size, and 
MSI. Being able to accurately quantify MI size using a pixel-wise acute ECV map 
would be appealing, and could be potentially easily implemented in clinical practice 
with the wider availability of in-line, automated ECV map generation from the 
scanner, to improve workflow 4. However, there are several potential limitations to 
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consider concerning the use of acute ECV maps to detect the AAR, chronic MI size 
and MSI in reperfused STEMI patients.  
Firstly, the study did not specifically compare the performance of ECV-
derived MSI with conventional MSI (from LGE and T2-STIR), and whether acute 
ECV maps can be used to estimate the MSI remains to be demonstrated. The authors 
could have considered using the reference standard of manual delineation of AAR and 
MI size by experienced operators, rather than semi-automated thresholding methods, 
which are known to have their limitations 5, 6. The presence of microvascular 
obstruction (MVO) on the acute CMR scan is known to pseud -normalize the ECV 5, 
7, due to failure of the gadolinium chelate to penetrate areas of MVO, which could 
have affected MI size regression, thereby making it challenging to estimate chronic 
MI size from the acute ECV in patients wi h MVO. Finally, the study used ≤75% 
transmural MI on the follow-up CMR scan to define viable myocardium, and an 
increase of ≥15% in left ventricular (LV) end-systolic volume to define adverse LV 
remodeling, instead of the conventionally accepted definitions of ≤50% for viability 
on CMR 8, and ≥20% increase in LV end-diastolic volume for adverse LV remodeling 
on echocardiography 9. In this regard, we have recently proposed CMR-based 
definitions for assessing adverse LV remodeling following STEMI, which may be 
helpful for future CMR studies 10. The study findings are also thought-provoking, and 
raise some interesting questions for the field.  
Can acute ECV maps be used to accurately delineate the chronic MI size 
given the pathological differences that exist between acute and chronic MI?  
It is well-recognized that acute MI size is dynamic, and acutely reduces in size within 
the first week 11, 12, and more chronically reduces over the first few months 5, 11. The 
regression in MI size represents the gradual resolution of myocardial edema, 
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intramyocardial hemorrhage (IMH) and MVO, and the gradual replacement of 
necrotic tissue with fibrosis in the chronic infarct 11. Furthermore, LV remodeling 
leads to thinning of the infarcted territory, and compensatory LV hypertrophy of the 
adjacent and remote myocardium, resulting in the overall reduction in LGE mass 
observed in the chronic phase. The over-estimation of acute MI size by LGE on the 
acute CMR scan can be minimized by acquiring LGE images at least 15 minutes after 
contrast injection and undertaking the acute CMR scan at day 7 13. In addition, acute 
MI size has recently been shown to be prognostic 14, and may help to reduce sample 
size in clinical cardioprotection studies in reperfused STEMI patients, thereby 
obviating the need to measure chronic MI size, which can be challenging to perform 
in clinical cardioprotection studies 6. Therefore, the differences between the 
pathologies underlying acute and chronic MI, may in part, have impacted on the study 
findings, and may have contributed to the substantial variability observed between 
acute MI size by ECV and chronic MI size by LGE, with the Bland-Altman analysis 
showing a bias of 1.9% and wide limits of agreement of ±10.5%. This suggests that 
acute ECV maps may not yet be ready to measure chronic MI size following STEMI.  
Can acute ECV maps be used to accurately delineate the AAR given that 
edema in salvaged myocardium can be both intracellular and interstitial following 
STEMI?  
During acute myocardial ischemia, interruption of the blood supply to the 
myocardium disrupts cardiomyocyte Na+/K+ channel function, leading to increased 
trans-membrane Na+ gradients and intracellular edema. Prolonged periods of ischemia 
can result in cardiomyocyte cell membrane rupture, thereby adding to the intracellular 
edema. Alterations in capillary permeability can promote interstitial edema, resulting 
in both intracellular and interstitial edema during acute myocardial ischemia. 
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Furthermore, reperfusion can exacerbate both interstitial and intracellular edema, and 
may also lead to extravasation of red blood cells15. Native T1-mapping, T2-mapping 
or T2-STIR CMR imaging detect both intracellular and interstitial edema, whereas 
acute ECV can only detect edema in the latter compartment 16, and therefore areas of 
intracellular edema in the salvaged myocardium may be overlooked by acute ECV.   
It may also be challenging for acute ECV maps to reliably differentiate 
salvaged myocardium within the AAR from remote myocardium outside the AAR, 
given that there can be overlap in acute ECV values between the salvaged and remote 
myocardium following STEMI. In this regard, Hammer-Hansen et al 17 have recently 
reported an overlap in acute ECV values between salvaged versus remote 
myocardium (95% of the acute ECV values were 18 - 30% in the remote, and 28 - 
51% in the salvaged myocardium) following STEMI. An overlap in acute ECV values 
between the salvaged and remote myocardium may also have affected the study by 
Garg et al 3, with areas of acute ECV >33% observed in the remote myocardium (see 
figure 3, case 1). Furthermore, a previous study by the same research group had 
reported an acute ECV of 29±6% in the remote myocardium 18, confirming the 
potential for overlap in acute ECV values between salvaged and remote myocardium. 
Again, this may explain, in part, the wide limits of agreement (±10.4%) observed in 
the current study, indicating a large variability in the observed values between acute 
ECV AAR and T2-STIR AAR 3. In a previous study, we had observed limits of 
agreement of ±5.1% when comparing T1 and T2-mapping to detect the AAR in 
reperfused STEMI patients 2, and limits of agreement of ±10.4% observed with acute 
ECV maps for delineating T2-weighted AAR may be too wide for clinical 
application. This suggests that acute ECV maps may not yet be ready to measure 
AAR following STEMI. 
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In summary, performing a comprehensive CMR study in acutely reperfused 
STEMI patients can be very challenging, and Garg et al 3 should be congratulated on 
their study investigating the potential role of acute ECV mapping for assessing AAR, 
chronic MI size and MSI. Although, multi-parametric CMR mapping has the real 
potential to provide valuable insights into the changes occurring in areas of MI, 
MVO, IMH, salvaged and remote myocardium in the setting of STEMI 7, 19, 20, more 
validation work is needed before acute ECV mapping, can be used to reliably assess 
AAR, MI size, and MSI in reperfused STEMI patients. 
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